How much of a problem is resistance in treating hepatitis C?

Curr Opin Infect Dis

aDepartment of Gastroenterology and Hepatology, St George's University Hospitals NHS Foundation Trust bSt George's University of London, London, UK.

Published: December 2016

AI Article Synopsis

  • Directly acting antiviral drugs (DAAs) show over 90% success in curing hepatitis C, but treatment failure often occurs due to the emergence of resistance-associated variants (RASs).
  • Research has identified specific amino acid changes in the virus that can reduce DAA effectiveness; these RASs may not always lead to treatment failure but can persist long after therapy.
  • Current guidelines suggest using optimal treatment strategies tailored to individual patient characteristics to minimize resistance, while next-generation DAAs are expected to be more effective and serve as backup options for those who experience treatment failure.

Article Abstract

Purpose Of Review: Directly acting antiviral drug (DAA) treatments represent a major advance in hepatitis C management, achieving virological cures in excess of 90%. When treatment failure occurs, it is mostly due to relapse with the emergence of resistance-associated variants.

Recent Findings: Data from in-vitro studies and clinical trials have enabled characterization of the amino acid substitutions in antiviral drug targets that confer reduced susceptibility to DAAs. These resistance-associated substitutions (RASs) may exist prior to treatment, and are associated with, but do not inevitably result in, treatment failure. The most important RASs with current regimens occur in the NS5A protein of viral variants, which may persist for years after treatment. The optimal strategy is to prevent resistance through administering the best treatment, appropriately matched to patient and virological characteristics, for example the presence of cirrhosis, prior exposure to interferon and so on.

Summary: International treatment guidelines have been developed to select treatments, which may vary in duration and coadministration with ribavirin. Routine resistance testing prior to treatment of naive patients is not generally recommended. Next-generation DAAs will further reduce the emergence of RASs and, because of activity against RASs to currently used DAAs, will be used as rescue therapies for patients who have failed treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1097/QCO.0000000000000319DOI Listing

Publication Analysis

Top Keywords

antiviral drug
8
treatment
8
treatment failure
8
prior treatment
8
daas will
8
problem resistance
4
resistance treating
4
treating hepatitis
4
hepatitis purpose
4
purpose review
4

Similar Publications

Taking the natural product cerbinal as the lead compound, 30 novel 5-aryl-cyclopenta[]pyridine derivatives were designed and synthesized based on the previous bioactivity studies of the cyclopenta[]pyridines. The modification of the position-5 of compound was achieved by amination, bromination, and cross coupling using cerbinal as the raw material. The results of the bioactivity tests demonstrated that partial compounds exhibited superior activity against plant viruses compared to compound .

View Article and Find Full Text PDF

Potent antiviral action detected in extracts against .

Drug Dev Ind Pharm

January 2025

Laboratory of Virology and Cellular Technology, Department of Chemistry, Biotechnology, and Bioprocess Engineering, Universidade Federal de São João del-Rei, Ouro Branco, MG, Brazil.

Background: , a notable plant species, has garnered interest for its medicinal properties, including anti-inflammatory, antibacterial and antiviral effects. A vaccine for Chikungunia virus is still under evaluation and no specific antiviral drug has been licensed to date.

Objective: The work investigated antiviral activity of ethyl acetate (EAEF) and methanolic (EMF) extracts from leaves in mammalian cells exposed to (CHIKV).

View Article and Find Full Text PDF

Combating COVID-19 and its co-infection by Aspergillus tamarii SP73-EGY using in vitro and in silico Studies.

Sci Rep

January 2025

Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, 33 El Buhouth St, Dokki-Giza, Egypt.

The COVID-19 pandemic has caused significant mortality and morbidity for millions of people. Severe Acute Respiratory Syndrome-2 (SARS-CoV-2) virus is capable of causing severe and fatal diseases. We evaluated the antiviral properties of Aspergillus tamarii SP73-EGY isolate extract against low pathogenic coronavirus (229E), Adeno-7- and Herpes-2 viruses.

View Article and Find Full Text PDF

Lessons from COVID-19 in Taiwan's long-term care facilities: A narrative review.

J Formos Med Assoc

January 2025

Department of Internal Medicine, National Taiwan University Hospital, No.7, Chung Shan S. Rd.(Zhongshan S. Rd.), Zhongzheng Dist., Taipei City, 100225, Taiwan, ROC; College of Medicine, National Taiwan University, No.1 Jen Ai road section 1, Taipei 100, Taiwan, ROC. Electronic address:

The coronavirus Disease 2019 (COVID-19) pandemic has disproportionately impacted long-term care facilities (LTCFs), revealing vulnerabilities due to residents' advanced age, comorbidities, and facility infrastructures. In Taiwan, the Central Epidemic Control Center implemented a range of strategies to protect LTCF residents. These included early containment measures to allow time for preparing pharmaceutical intervention, the establishment of infection prevention and control guidelines, the implementation of comprehensive screening and testing protocols, the prioritization of vaccination for both residents and staff, and the expansion of the national stockpile of oral antiviral agents.

View Article and Find Full Text PDF

Extraction methods, structural features and bioactivity diversity of polysaccharides from the genus Chrysanthemum: A review.

Int J Biol Macromol

January 2025

Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, P. R. China; School of Pharmacy, North Sichuan Medical College, Nanchong, Sichuan, 637000, P. R. China. Electronic address:

The genus Chrysanthemum has been widely used as both folk medicine and food in East Asia for thousands of years, serving as a significant source of nutritional and pharmacological value. According to the theory of traditional Chinese medicine, it clears heat and toxic materials and regulates liver function. Accumulating evidence has demonstrated that polysaccharides from the genus Chrysanthemum, especially Chrysanthemum morifolium, Chrysanthemum indicum, and Coreopsis tinctoria, are vital representative macromolecules with diverse biological activities, including antioxidant, immunomodulatory, anti-inflammatory, hypoglycemic, antitumor, and antiviral properties as well as the ability to regulate the gut microbiota.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!